ClinicalTrials.gg
Status unknownNCT05245799Updated Mar 30, 2023

Hear Me Read 2021 Clinical Trial

An interventional study of Speech Language Therapy and Digital Software Application in Hearing Loss, Deafness and Hearing Disorders in Children, sponsored by Prasanth Pattisapu. Status unknown at 1 site in United States. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2023-03-30.

Primary conditionDeafnessRegistry: Hearing LossReclassifiedWhy we changed it
Registry
Hearing Loss — the first condition term the registry derived for this study.
ClinicalTrials.gg
Deafness
Why
  1. The study's listed conditions name Deafness, a narrower term within Hearing Loss.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Prasanth Pattisapu · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate if the effects of in-person speech-language therapy with a novel digital storybook intervention platform (Hear Me Read) improves vocabulary, speech and language, and literacy outcomes in young children who are deaf or hard of hearing compared with in-person therapy alone.

Read the detailed description

For this study, 50 children, who are deaf/hard of hearing, and their caregiver will be enrolled into 2 separate 6-month intervention periods, for a total of 12 months of participation. There are two intervention periods in this study, Intervention Period 1 (SLT) and Intervention Period 2 (SLT+Digital). Each one lasts about 6 months and every participant will participate in both intervention periods.

Intervention Period 1 is the speech-language therapy (SLT) only intervention. During this intervention, the child will go to speech therapy as normally prescribed by their speech language pathologist. There will be standardized reading time that is prescribed at 20 minutes, 3 times a week and will be completed at home by the child and caregiver.

Intervention Period 2 is the speech-language therapy with the Hear Me Read (SLT+Digital) intervention. During this intervention, the child will continue to go to speech therapy as they typically would, but will be asked to use the Hear Me Read app. There will be standardized reading time that is prescribed at 20 minutes, 3 times a week and will be completed at home by the child and caregiver using the Hear Me Read app.

02

Conditions studied

  • Hearing Loss
  • Deafness
  • Hearing Disorders in Children
  • Hearing Impaired Children
  • Speech Therapy
  • Speech Disorders in Children
  • Literacy

Keywords

  • App
  • Speech and Language
  • Tablet
  • Digital
  • Literacy
  • Hearing Loss
  • Speech Therapy
03

In context

Deafness Reclassified

160 studies on the registry are indexed under Deafness; 46 are open to participants now.

This study's planned enrollment of 50 is above the median of 43 across 106 interventional studies indexed under Deafness.

Browse Deafness studies →

Lead sponsor

This is the only study on the registry with Prasanth Pattisapu as lead sponsor.

Compared within Deafness, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hearing Loss. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female children ages 3.0-5.11 (5 years and 11 months) at time of initial assessment and:
  • Bilateral Sensorineural or mixed hearing loss at least (PTA≥30dB)
  • Auditory neuropathy in both ears

Exclusion criteria

Exclusion Criteria:

  • English not primary language
  • Standard score CLS >2 SD from normal on CELF-P3
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Speech Language Therapy

    Children who are deaf/hard of hearing will receive standard of care speech and language therapy with a speech language pathologist. Reading time is prescribed 20 min, 3x/week.

    Behavioral: Speech Language Therapy

  • Experimental
    Speech Language Therapy + Digital Phase

    Children who are deaf/hard of hearing will receive standard of care speech and language therapy with a speech language pathologist with the addition of the digital app named, Hear Me Read, that will be used to achieve reading, speech and language goals through interactive digital storybook reading. Reading time is prescribed 20 min, 3x/week.

    Behavioral: Speech Language Therapy · Behavioral: Digital Software Application

Interventions

  • BehavioralSpeech Language Therapy

    Children who are deaf/hard of hearing will receive typical speech and language therapy with a speech pathologist. Reading time is prescribed 20 min, 3x/week.

  • BehavioralDigital Software Application

    The Hear Me Read app is an IOS-based software application that enables parents and speech-language pathologists to partner together to help deaf/hard of hearing children (D/HH) achieve reading, speech and language goals through interactive digital storybook reading.

    Also known as: Hear Me Read

06

What researchers measure

Primary outcomes

  1. Receptive One Word Picture Vocabulary Test

    The ROWPVT-4 is an individually administered assessment of how well persons can match a word that is heard to objects, actions, or concepts presented in full-color pictures. The examinee indicates the correct color picture that matches the word spoken by the examiner. Raw scores are reported as standard scores, percentile ranks, growth scale and age equivalents. Raw scores are from 0-100 with higher scores indicating better performance.

    Time frame: 12- month intervention period

  2. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Sentence Comprehension

    The Sentence Comprehension (SC) subtest is used to evaluate the child's ability to interpret spoken sentences of increasing length and complexity. The child identifies a picture that matches the sentence read aloud by the examiner. Raw scores (min = 0; max = 22) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher scaled scores represent better language outcomes.

    Time frame: 12- month intervention period

  3. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Word Structure

    The Word Structure (WS) subtest is used to evaluate the child's ability to (a) apply word structure rules to mark inflections, derivations, and comparison and (b) select and use appropriate pronouns to refer to people, objects, and possessive relationships. Raw scores (min = 0; max = 24) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  4. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Expressive Vocabulary

    The Expressive Vocabulary (EV) subtest is used to evaluate the child's ability to label images of people, objects, attributes, and actions. The child names an object, person, or activity portrayed in a picture. Raw scores (min = 0; max = 42) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  5. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Following Directions

    The Following Directions (FD) subtest is used to evaluate the child's ability to (a) interpret spoken directions of increasing length and complexity; (b) remember the names, characteristics, and order of mention of pictures; and (c) identify the targets from among several choices. Raw scores (min = 0; max = 24) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  6. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Recalling Sentences

    The Recalling Sentences (RS) subtest is used to evaluate the child's ability to listen to spoken sentences of increasing length and complexity and repeat the sentences without changing word meanings, inflections, derivations or comparisons, or sentence structure. Raw scores (min = 0; max = 45) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  7. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Basic Concepts

    The Basic Concepts (BC) subtest is used to evaluate the child's knowledge of concepts including direction/location/position, number/quantity, sequence, attributes, dimension/size, same/different, and inclusion/exclusion. Raw scores (min = 0; max = 24) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  8. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Word Classes

    The Word Classes (WC) subtest is used to evaluate the child's ability to perceive relationships between words that are related by semantic class features. Raw scores (min = 0; max = 20) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  9. Clinical Evaluation of Language Fundamentals Preschool- 3: Core Language Score

    The Core Language Score (CLS) is a measure of general language ability that quantifies overall language performance and is used to make decisions about the presence or absence of a language disorder. It is derived by summing the scaled scores from the subtests that best discriminate typical language performance from disordered language performance deriving a standardized composite score (min = 45; max = 155). Higher composite scores represent better language outcomes.

    Time frame: 12- month intervention period

  10. Clinical Evaluation of Language Fundamentals Preschool- 3 and Indices: Receptive Language Index

    The Receptive Language Index (RLI) is a measure of listening and auditory comprehension and is derived by summing the scaled scores from a combination of two or three receptive subtests. Scores are derived by summing the scaled scores from the subtests and deriving a standardized composite score (min = 45; max = 155). Higher composite scores represent better language outcomes.

    Time frame: 12- month intervention period

  11. Clinical Evaluation of Language Fundamentals Preschool- 3 and Indices: Expressive Language Index

    The Expressive Language Index (ELI) is a measure of performance on three tests that probe expressive aspects of language including oral language expression. Scores are derived by summing the scaled scores from the subtests and deriving a standardized composite score (min = 45; max = 155). Higher composite scores represent better language outcomes.

    Time frame: 12- month intervention period

Secondary outcomes

  1. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Phonological Awareness

    The Phonological Awareness (PA) subtest is used to evaluate the child's knowledge of the sound structure of language and ability to manipulate sound through compound word and syllable blending, sentence and syllable segmentation, and rhyme awareness and production. Raw scores (min = 0; max = 24) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  2. Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Preliteracy Rating Scale

    The Preliteracy Rating Scale (PRS) subtest is used to identify preliteracy skills that may influence development of reading and writing skills. The examiner provides or elicits information from a respondent about the child's early reading and writing skills. Raw scores (min = 0; max = 105) are reported as standard scores, percentile ranks, growth scale and age equivalents. Higher standard scores represent better language outcomes.

    Time frame: 12- month intervention period

  3. Clinical Evaluation of Language Fundamentals Preschool-3 Index: Early Literacy Index

    Early Literacy Index (ELI) is a measure of performance on two subtests designed to assess early literacy skills. Scores are derived by summing the scaled scores from the subtests and deriving a standardized composite score (min = 45; max = 155). Higher composite scores represent better language outcomes.

    Time frame: 12- month intervention period

07

Study locations

1 site
  • Nationwide Children's Hospital
    Columbus, Ohio 43205, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05245799
Lead sponsor
Prasanth Pattisapu
Collaborators
Clinical and Translational Intramural Funding Program from the Abigail Wexner Research Institute
Responsible party
Prasanth Pattisapu (Principal Investigator, Nationwide Children's Hospital) — Sponsor-investigator
First posted
Feb 18, 2022
Start date
Mar 25, 2022
Primary completion
Mar 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Mar 30, 2023

Study contacts

Prasanth Pattisapu, MD
principal investigator · Nationwide Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion